Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Hong Kong Science Park West Avenue, Unit 101-102,building 6w,hong Kong
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.geneditbio.com/
- Keywords
- IT Consulting.
- HQ
- Hong Kong
Geneditbio Limited Questions
Geneditbio Limited's website is https://www.geneditbio.com/
Geneditbio Limited's LinkedIn profile is https://hk.linkedin.com/company/geneditbio-limited
Geneditbio Limited has
22 employees.
View email and phone details for 22
employees at Geneditbio Limited.
Geneditbio Limited's industry is
Biotechnology Research
Geneditbio Limited's top competitors are
Jacobio Pharma,
Prenetics,
Immuno Cure,
Ori Capital,
Applied Technology Group Limited,
Phase Scientific International Limited,
Centre For Translational Stem Cell Biology (Ctscb),
Innorna Co., Ltd.,
Hkstp - Hong Kong Science And Technology Parks Corporation,
Genedit.
Geneditbio Limited's categories are Biotechnology Research
Geneditbio Limited's founding year is 2021
